Fundraising FoxNeuroFlow
Philadelphia, US · Founded 2017 · Delaware corporation · 14 known investors
Find your way into NeuroFlow
Sign up to see every warm intro you have to NeuroFlow
- Paths you didn't know you had: your email and LinkedIn already hold routes to the NeuroFlow team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NeuroFlow builds behavioral health integration platforms that identify population behavioral health risk, engage individuals with acuity-specific resources, and give care teams data to make decisions. It serves healthcare organizations and health systems aiming to improve outcomes and lower total cost of care.
Founders & leadership
NeuroFlow was founded in 2017 by Christopher Molaro and Adam Pardes.
Investors · 14
How we know: Corewell Health Ventures's portfolio page · Not right? Tell us
How we know: Dreamit Ventures's portfolio page · bhbusiness.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Echo Health Ventures's portfolio page · Not right? Tell us
How we know: First Trust Capital Partners's portfolio page · Not right? Tell us
How we know: HLM Investment Partners's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: JumpStart New Jersey Angel Network's portfolio page · Not right? Tell us
How we know: MemorialCare Innovation Fund's portfolio page · Not right? Tell us
How we know: Red & Blue Ventures's portfolio page · bhbusiness.com · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: a partner's Signal profile · bhbusiness.com · Not right? Tell us
How we know: funding news · Not right? Tell us
Also in the syndicate · 3
Reported raises · per SEC filings
Form D private placements$45.4M disclosed across 5 rounds · 2017–2022
▶$25.5MraisedOct 2022 · 19 investors · Other TechnologyRule 506(b)
- Mark McAdooDirector
- Mark GoldsteinDirector
- Christopher MolaroExecutive Officer, Director
- Adam PardesExecutive Officer, Director
- Mark MillerDirector
- Alan Wayne TamarelliDirector
- Enrico PicazzoDirector
- Offering amount
- $35M
- Amount sold
- $25.5M
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11MraisedJan 2021 · 4 investors · Other TechnologyRule 506(b)
- Mark GoldsteinDirector
- Alan Wayne TamarelliDirector
- Adam PardesExecutive Officer, Director
- Christopher MolaroExecutive Officer, Director
- Offering amount
- $20M
- Amount sold
- $11M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$6.9MraisedDec 2019 · 7 investors · Other TechnologyRule 506(b)
- Christopher MolaroExecutive Officer, Director
- Mark GoldsteinDirector
- Alan Wayne TamarelliDirector
- Adam PardesExecutive Officer, Director
- Offering amount
- $7.5M
- Amount sold
- $6.9M
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$1.1MraisedAug 2018 · 16 investors · Other TechnologyRule 506(b)
- Christopher MolaroExecutive Officer, Director
- Alan Wayne TamarelliDirector
- Adam PardesExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.1M
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$906.3KraisedOct 2017 · 11 investors · Other TechnologyRule 506(b)
- Alan Wayne TamarelliDirector
- Christopher MolaroExecutive Officer, Director
- Adam PardesExecutive Officer, Director
- Offering amount
- $1.3M
- Amount sold
- $906.3K
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Companies working in the same space as NeuroFlow.
Non-dilutive funding · 5 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| U.S. Air ForceAir Force | Phase II | 2022 | $1.7M |
| National Science Foundation | Phase II | 2020 | $749.4K |
| U.S. Air ForceAir Force | Phase I | 2020 | $48.4K |
| U.S. Air ForceAir Force | Phase I | 2019 | $48.4K |
| National Science Foundation | Phase ISTTR | 2018 | $224.5K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does NeuroFlow do?
- NeuroFlow builds behavioral health integration platforms that identify population behavioral health risk, engage individuals with acuity-specific resources, and give care teams data to make decisions. It serves healthcare organizations and health systems aiming to improve outcomes and lower total cost of care.
- Who founded NeuroFlow?
- NeuroFlow was founded by Christopher Molaro, Adam Pardes in 2017.
- Who are NeuroFlow's investors?
- NeuroFlow's investors include Corewell Health Ventures, Dreamit Ventures, Echo Health Ventures, First Trust Capital Partners, HLM Investment Partners, JumpStart New Jersey Angel Network, MemorialCare Innovation Fund, Red & Blue Ventures and 3 more.
- How much funding has NeuroFlow raised?
- NeuroFlow has disclosed $45.4M raised across 5 rounds.
- Where is NeuroFlow headquartered?
- NeuroFlow is headquartered in Philadelphia, US.